Nonproliferative Diabetic Retinopathy
4 clinical trials · Condition
◉ Watch Nonproliferative Diabetic Retinopathy
| Record | Firm | Date |
|---|---|---|
| The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) (NCT03197870) | EyePoint Pharmaceuticals, Inc. | 2017-06-09 |
| Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy (NCT02834663) | Wonkwang University Hospital | 2016-08-01 |
| Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR) (NCT02718326) | Regeneron Pharmaceuticals | 2016-03-29 |
Track Nonproliferative Diabetic Retinopathy automatically
Every clearance here is in the API, with alerts when new ones post.